REPORTS

Let’s Pullulate and Expand Your Business

Exosome Market - Global Professional Analysis and Forecast to 2026

Oct 10, 2019  |  161 PAGES  |  REPORT CODE: CMM203488
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Exosome market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.4% during the forecast period.

This report presents the market size and development trends by detailing the Exosome market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Exosome market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Exosome industry and will help you to build a panoramic view of the industrial development.

Exosome Market, By Type:

  • sdfsd

  • sfddsf

Exosome Market, By Application:

  • Hospital and Diagnostic Centers

  • Exosomal Proteins as Diagnostic Biomarkers

  • Exosome Nucleic Acids as Diagnostics Biomarkers

  • Exosomes: Novel Biomarkers for Clinical Diagnosis

  • Others: Pharmaceutical and Life Science Industries and Academic Institutes

Some of the leading players are as follows:

  • NX Pharmagen

  • Sistemic

  • NX Prenatal

  • Ymir Genomics

  • Exosome Sciences/Aethlon Medical

  • Exosome Diagnostics

  • NanoSomiX

  • Orion Pharma

  • Amarantus BioScience

  • Caris Life Sciences

  • Exosomics Siena SPA

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Exosome Market: Technology Type Analysis

  • 4.1 Exosome Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Exosome Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 sdfsd

    • 4.3.2 sfddsf

5 Exosome Market: Product Analysis

  • 5.1 Exosome Product Market Share Analysis, 2018 & 2026

  • 5.2 Exosome Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Exosome Market: Application Analysis

  • 6.1 Exosome Application Market Share Analysis, 2018 & 2026

  • 6.2 Exosome Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital and Diagnostic Centers

    • 6.3.2 Exosomal Proteins as Diagnostic Biomarkers

    • 6.3.3 Exosome Nucleic Acids as Diagnostics Biomarkers

    • 6.3.4 Exosomes: Novel Biomarkers for Clinical Diagnosis

    • 6.3.5 Others: Pharmaceutical and Life Science Industries and Academic Institutes

7 Exosome Market: Regional Analysis

  • 7.1 Exosome Regional Market Share Analysis, 2018 & 2026

  • 7.2 Exosome Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 NX Pharmagen

    • 9.1.1 NX Pharmagen Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Sistemic

    • 9.2.1 Sistemic Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 NX Prenatal

    • 9.3.1 NX Prenatal Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Ymir Genomics

    • 9.4.1 Ymir Genomics Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Exosome Sciences/Aethlon Medical

    • 9.5.1 Exosome Sciences/Aethlon Medical Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Exosome Diagnostics

    • 9.6.1 Exosome Diagnostics Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 NanoSomiX

    • 9.7.1 NanoSomiX Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Orion Pharma

    • 9.8.1 Orion Pharma Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Amarantus BioScience

    • 9.9.1 Amarantus BioScience Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Caris Life Sciences

    • 9.10.1 Caris Life Sciences Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Exosomics Siena SPA

    • 9.11.1 Exosomics Siena SPA Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 65 Figures and 161 Tables)

  • Figure sdfsd Exosome market, 2015 - 2026 (USD Million)

  • Figure sfddsf Exosome market, 2015 - 2026 (USD Million)

  • Figure Hospital and Diagnostic Centers market, 2015 - 2026 (USD Million)

  • Figure Exosomal Proteins as Diagnostic Biomarkers market, 2015 - 2026 (USD Million)

  • Figure Exosome Nucleic Acids as Diagnostics Biomarkers market, 2015 - 2026 (USD Million)

  • Figure Exosomes: Novel Biomarkers for Clinical Diagnosis market, 2015 - 2026 (USD Million)

  • Figure Others: Pharmaceutical and Life Science Industries and Academic Institutes market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Exosome market, by country, 2015 - 2026 (USD Million)

  • Table North America Exosome market, by type, 2015 - 2026 (USD Million)

  • Table North America Exosome market, by product, 2015 - 2026 (USD Million)

  • Table North America Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Exosome market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Exosome market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Canada Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Canada Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Europe Exosome market, by country, 2015 - 2026 (USD Million)

  • Table Europe Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Europe Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Europe Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Exosome market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Exosome market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Germany Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Germany Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Exosome market, by type, 2015 - 2026 (USD Million)

  • Table France Exosome market, by product, 2015 - 2026 (USD Million)

  • Table France Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Italy Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Italy Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Spain Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Spain Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exosome market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Exosome market, by type, 2015 - 2026 (USD Million)

  • Table China Exosome market, by product, 2015 - 2026 (USD Million)

  • Table China Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Japan Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Japan Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Exosome market, by type, 2015 - 2026 (USD Million)

  • Table India Exosome market, by product, 2015 - 2026 (USD Million)

  • Table India Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Exosome market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Exosome market, by application, 2015 - 2026 (USD Million)

  • Table MEA Exosome market, by country, 2015 - 2026 (USD Million)

  • Table MEA Exosome market, by type, 2015 - 2026 (USD Million)

  • Table MEA Exosome market, by product, 2015 - 2026 (USD Million)

  • Table MEA Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Exosome market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Exosome market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Exosome market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Exosome market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Exosome market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table NX Pharmagen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sistemic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NX Prenatal Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ymir Genomics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Exosome Sciences/Aethlon Medical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Exosome Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NanoSomiX Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Orion Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amarantus BioScience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Caris Life Sciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Exosomics Siena SPA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top